Omni Bio Pharmaceutical Inc (OTCBB - OTC Pink Current Information:OMBP)

Data as of Jan 23
 -0.06 / -17.14%
Today’s Change
Today|||52-Week Range

Company Description

Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company. explore new methods of use of alpha-1 antitrypsin (AAT). AAT is a naturally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. The company was founded on December 1, 2005 and is headquartered in Fort Collins, CO.

Contact Information

Omni Bio Pharmaceutical, Inc.
181 West Boardwalk Drive
Fort Collins Colorado 80525
P:(970) 237-5178
Investor Relations:



Individual stakeholders32.51%
Mutual fund holders--
Other institutional--

Top Executives

Bruce E. SchneiderChairman & Chief Executive Officer
John F. RiccardiChief Financial Officer
Charles A. DinarelloChief Scientific Officer
Bruce D. ForrestChief Development Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.